These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 27230587

  • 1. Effects of Pretreatment with Warfarin or Rivaroxaban on Neurovascular Unit Dissociation after Tissue Plasminogen Activator Thrombolysis in Ischemic Rat Brain.
    Shang J, Yamashita T, Kono S, Morihara R, Nakano Y, Fukui Y, Li X, Hishikawa N, Ohta Y, Abe K.
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):1997-2003. PubMed ID: 27230587
    [Abstract] [Full Text] [Related]

  • 2. Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat.
    Kono S, Yamashita T, Deguchi K, Omote Y, Yunoki T, Sato K, Kurata T, Hishikawa N, Abe K.
    Stroke; 2014 Aug; 45(8):2404-10. PubMed ID: 24984746
    [Abstract] [Full Text] [Related]

  • 3. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
    Kono S, Deguchi K, Omote Y, Yunoki T, Yamashita T, Kurata T, Ikeda Y, Abe K.
    J Neurosci Res; 2014 Jan; 92(1):46-53. PubMed ID: 24265137
    [Abstract] [Full Text] [Related]

  • 4. Reduction of intracerebral hemorrhage by rivaroxaban after tPA thrombolysis is associated with downregulation of PAR-1 and PAR-2.
    Morihara R, Yamashita T, Kono S, Shang J, Nakano Y, Sato K, Hishikawa N, Ohta Y, Heitmeier S, Perzborn E, Abe K.
    J Neurosci Res; 2017 Sep; 95(9):1818-1828. PubMed ID: 28035779
    [Abstract] [Full Text] [Related]

  • 5. Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice.
    Takamiya M, Miyamoto Y, Yamashita T, Deguchi K, Ohta Y, Abe K.
    Neuroscience; 2012 Sep 27; 221():47-55. PubMed ID: 22766232
    [Abstract] [Full Text] [Related]

  • 6. Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke.
    Ploen R, Sun L, Zhou W, Heitmeier S, Zorn M, Jenetzky E, Veltkamp R.
    J Cereb Blood Flow Metab; 2014 Mar 27; 34(3):495-501. PubMed ID: 24346690
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia.
    Deguchi K, Liu N, Liu W, Omote Y, Kono S, Yunoki T, Deguchi S, Yamashita T, Ikeda Y, Abe K.
    J Neurosci Res; 2014 Nov 27; 92(11):1509-19. PubMed ID: 24938625
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thrombolysis with rt-PA under Rivaroxaban Anticoagulation in a Hypertensive Rat Model of Intraluminal Middle Cerebral Artery Occlusion.
    Izuma H, Oka F, Ishihara H, Inoue T, Suehiro E, Nomura S, Suzuki M.
    J Stroke Cerebrovasc Dis; 2018 Oct 27; 27(10):2761-2767. PubMed ID: 30056000
    [Abstract] [Full Text] [Related]

  • 13. Direct arterial damage and neurovascular unit disruption by mechanical thrombectomy in a rat stroke model.
    Sasaki R, Yamashita T, Tadokoro K, Matsumoto N, Nomura E, Omote Y, Takemoto M, Hishikawa N, Ohta Y, Abe K.
    J Neurosci Res; 2020 Oct 27; 98(10):2018-2026. PubMed ID: 32557772
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR, Hellkamp AS, Lokhnygina Y, Piccini JP, Zhang Z, Mohanty S, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Becker RC, Nessel CC, Berkowitz SD, Califf RM, Fox KA, Mahaffey KW.
    J Am Coll Cardiol; 2013 Feb 12; 61(6):651-8. PubMed ID: 23391196
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. SMTP-7, a new thrombolytic agent, decreases hemorrhagic transformation after transient middle cerebral artery occlusion under warfarin anticoagulation in mice.
    Ito A, Niizuma K, Shimizu H, Fujimura M, Hasumi K, Tominaga T.
    Brain Res; 2014 Aug 26; 1578():38-48. PubMed ID: 25016287
    [Abstract] [Full Text] [Related]

  • 18. Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation.
    Piccini JP, Hellkamp AS, Washam JB, Becker RC, Breithardt G, Berkowitz SD, Halperin JL, Hankey GJ, Hacke W, Mahaffey KW, Nessel CC, Singer DE, Fox KA, Patel MR.
    Circulation; 2016 Jan 26; 133(4):352-60. PubMed ID: 26673560
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats.
    Liu W, Yamashita T, Kurata T, Kono S, Hishikawa N, Deguchi K, Zhai Y, Abe K.
    Neurol Res; 2015 Jun 26; 37(6):491-501. PubMed ID: 25591419
    [Abstract] [Full Text] [Related]

  • 20. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.
    Tai SH, Chen HY, Lee EJ, Chen TY, Lin HW, Hung YC, Huang SY, Chen YH, Lee WT, Wu TS.
    J Pineal Res; 2010 Nov 26; 49(4):332-41. PubMed ID: 20663046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.